{"id":69013,"date":"2026-03-13T11:58:53","date_gmt":"2026-03-13T11:58:53","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69013"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"kpv-lysine-proline-valine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/kpv-lysine-proline-valine\/","title":{"rendered":"KPV (Lisina-Prolina-Valina)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 KPV?<\/h3>\n<p style=\"margin: 0;\"><strong>KPV<\/strong> \u00e9 o tripept\u00eddeo Lys-Pro-Val \u2014 o fragmento C-terminal anti-inflamat\u00f3rio da hormona estimulante dos melan\u00f3citos alfa (\u03b1-MSH). Ao contr\u00e1rio dos an\u00e1logos mais amplos das melanocortinas, o KPV tem <strong>nenhuma atividade de pigmenta\u00e7\u00e3o<\/strong>; its signal is purely anti-inflammatory via NFkB inhibition and mast-cell stabilization. Studied for IBD, allergic inflammation, and skin-inflammation studies. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">67727-97-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>16<\/sub>H<sub>30<\/sub>N<sub>4<\/sub>O<sub>4<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">342,43 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lys-Pro-Val (\u03b1-MSH 11\u201313)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (ou conforme fornecido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar no prazo de ~30 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de utiliza\u00e7\u00e3o mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 KPV?<\/h2>\n<p><strong>KPV<\/strong> \u00e9 a abreviatura de tr\u00eas letras (c\u00f3digo de uma letra) para o <strong>tripept\u00eddeo Lys-Pro-Val<\/strong> \u2014 the C-terminal three amino acids (positions 11\u201313) of alpha-melanocyte stimulating hormone (\u03b1-MSH). In the 1980s\u20131990s, multiple groups noticed that the full \u03b1-MSH molecule produced two functionally separable effects: the well-known N-terminal MC-receptor pigmentation\/arousal activity, and a C-terminal <strong>anti-inflamat\u00f3ria<\/strong> activity. When the C-terminal KPV tripeptide was synthesised and tested in isolation, it reproduced the anti-inflammatory effects without the pigmentation side-effects. Molecular weight approximately 342.4\u00a0Da. KPV is one of the smallest peptides in the melanocortin family and one of the most-studied anti-inflammatory studies tripeptides. It is supplied as a high-purity lyophilized powder. For mechanism, IBD studies history, and stacking context, see our <a href=\"https:\/\/medsbase.com\/pt-pt\/kpv-peptide-anti-inflammatory-guide\/\">KPV guide<\/a>. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Tr\u00eas Vias Anti-Inflamat\u00f3rias<\/h2>\n<p>A atividade anti-inflamat\u00f3ria do KPV opera atrav\u00e9s de pelo menos tr\u00eas vias complementares, todas convergindo na redu\u00e7\u00e3o da sinaliza\u00e7\u00e3o inflamat\u00f3ria sem afetar outras fun\u00e7\u00f5es dos melanocortinas:<\/p>\n<ul>\n<li><strong>Inibi\u00e7\u00e3o do NFkB<\/strong> \u2014 O KPV bloqueia a transloca\u00e7\u00e3o do NFkB para o n\u00facleo, impedindo a transcri\u00e7\u00e3o de citocinas pr\u00f3-inflamat\u00f3rias, incluindo TNF-alfa, IL-6, IL-1\u03b2 e IL-8. O NFkB \u00e9 o regulador principal da express\u00e3o de genes inflamat\u00f3rios, portanto, bloquear a sua ativa\u00e7\u00e3o produz um efeito anti-inflamat\u00f3rio amplo e a montante.<\/li>\n<li><strong>Estabiliza\u00e7\u00e3o dos mast\u00f3citos<\/strong> \u2014 KPV reduces mast-cell degranulation and histamine release in study models. This is a distinct mechanism from NFkB inhibition and is particularly relevant to allergic-inflammation studies and topical skin-inflammation models.<\/li>\n<li><strong>Separa\u00e7\u00e3o pept\u00eddeo-vs-MSH<\/strong> \u2014 como o KPV \u00e9 apenas o fragmento C-terminal, ele <strong>n\u00e3o ativa o MC1R<\/strong> (o receptor de pigmenta\u00e7\u00e3o) ou o MC4R (o receptor de excita\u00e7\u00e3o\/alimenta\u00e7\u00e3o). Isto separa mecanicamente a atividade anti-inflamat\u00f3ria dos outros efeitos do \u03b1-MSH \u2014 distinto dos an\u00e1logos mais amplos dos MC, como <a href=\"https:\/\/medsbase.com\/pt-pt\/melanotan-ii\/\">Melanotan II<\/a> ou <a href=\"https:\/\/medsbase.com\/pt-pt\/pt-141\/\">PT-141<\/a>.<\/li>\n<\/ul>\n<p>The practical studies implication: KPV is a &#8220;clean&#8221; anti-inflammatory tool that produces the \u03b1-MSH anti-inflammatory signal without the tanning, arousal, or appetite-modulation effects that complicate interpretation of studies using full-length MC agonists. <\/p>\n<h2>Published Evidence<\/h2>\n<p>KPV is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>IBD and colitis studies<\/strong> \u2014 inflammatory bowel disease rodent models; KPV is active via both SC and oral routes, making it unusually flexible for GI-inflammation studies (Brzoska et al., Endocr Rev 2008)<\/li>\n<li><strong>Inflama\u00e7\u00e3o al\u00e9rgica<\/strong> \u2014 mast-cell stabilization and histamine-release studies in allergy and atopy models<\/li>\n<li><strong>Inflama\u00e7\u00e3o cut\u00e2nea<\/strong> \u2014 eczema, psoriasis, and contact-dermatitis study models; topical formulations appear in some protocols<\/li>\n<li><strong>Cicatriza\u00e7\u00e3o de feridas<\/strong> \u2014 anti-inflammatory phase of wound-healing studies, often paired with <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> para cobertura combinada anti-inflamat\u00f3ria e de fatores de crescimento<\/li>\n<li><strong>Inflama\u00e7\u00e3o articular<\/strong> \u2014 arthritis and joint-inflammation rodent study models<\/li>\n<li><strong>Stacking studies<\/strong> \u2014 frequentemente combinado com <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> in GI and connective-tissue studies where anti-inflammatory + tissue-repair coverage is needed<\/li>\n<li><strong>Melanocortin comparative studies<\/strong> \u2014 em compara\u00e7\u00e3o direta com <a href=\"https:\/\/medsbase.com\/pt-pt\/melanotan-ii\/\">Melanotan II<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/pt-141\/\">PT-141<\/a> para isolar os efeitos anti-inflamat\u00f3rios puros versus os efeitos nos recetores MC<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre p\u00e9ptidos anti-inflamat\u00f3rios e de cicatriza\u00e7\u00e3o, consulte a <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a>. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>A MedsBase disp\u00f5e de KPV nos seguintes tamanhos de frascos liofilizados:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing \u2014 supports ~10 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~20 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>KPV protocols span a range depending on model system \u2014 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies, or topical\/oral routes for GI and skin contexts. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Como Compara \u2014 KPV vs Outros P\u00e9ptidos Anti-Inflamat\u00f3rios \/ Melanocortinas<\/h2>\n<p>KPV is one of the cleanest anti-inflammatory peptides in use because its activity is so narrow. Compared to related compounds:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">KPV<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Melanotan II<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino\u00e1cidos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amino\u00e1cidos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (c\u00edclicos)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Atividade prim\u00e1ria<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Apenas anti-inflamat\u00f3ria<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anti-inflamat\u00f3ria + repara\u00e7\u00e3o tecidual + recetor de GH<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agonista amplo de MC (MC1-5)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Atividade do recetor MC<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhuma (apenas C-terminal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhum<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC1, MC3, MC4, MC5<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Efeito de pigmenta\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhum<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhum<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte (sinal prim\u00e1rio)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Study applications<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">DII, alergia, inflama\u00e7\u00e3o cut\u00e2nea<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Recupera\u00e7\u00e3o de tend\u00f5es, intestino, m\u00fasculos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Melanog\u00e9nese, fotoprote\u00e7\u00e3o<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For GI-inflammation studies, KPV + BPC-157 is a particularly common combination because KPV provides upstream anti-inflammatory signaling while BPC-157 provides tissue-repair growth-factor activity. This is covered in our <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a>. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazenar frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original, est\u00e1veis at\u00e9 36 meses. Evitar ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injetar \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco de pept\u00eddeo conforme o gr\u00e1fico acima. Agitar suavemente \u2014 n\u00e3o <strong>n\u00e3o<\/strong> agitar \u2014 e permitir 5\u201310 minutos para dissolu\u00e7\u00e3o completa. A solu\u00e7\u00e3o deve estar l\u00edmpida e incolor. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazenar refrigerado a 2\u20138\u00a0\u00b0C e utilizar dentro de 30 dias. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is KPV used for in studies?<\/h3>\n<p>KPV is used in studies investigating anti-inflammatory biology, inflammatory bowel disease (IBD) and colitis, allergic inflammation, skin inflammation (eczema\/psoriasis models), wound-healing inflammation phase, joint inflammation, and comparative melanocortin pharmacology. It is <strong>n\u00e3o<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>Em que \u00e9 que o KPV difere do Melanotan II ou do PT-141?<\/h3>\n<p>O KPV \u00e9 apenas o fragmento C-terminal de tr\u00eas amino\u00e1cidos da alfa-MSH, enquanto o Melanotan II e o PT-141 s\u00e3o an\u00e1logos completos ou quase completos da MSH c\u00edclica. Isto significa que o KPV tem <strong>nenhuma atividade nos recetores de melanocortina<\/strong> e, portanto, n\u00e3o tem efeitos na pigmenta\u00e7\u00e3o (MC1R), na excita\u00e7\u00e3o (MC4R) ou no apetite (MC4R) \u2014 apenas atividade anti-inflamat\u00f3ria via vias NFkB e mast\u00f3citos. <\/p>\n<h3>What is the typical KPV dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies. Some IBD and skin-inflammation uses oral or topical administration. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 10 ticks on a U-100 SC syringe delivers 500\u00a0mcg. <\/p>\n<h3>O KPV \u00e9 aprovado pela FDA?<\/h3>\n<p>No. KPV has not received FDA, EMA, or any regulatory approval. The full alpha-MSH peptide and KPV-related has informed melanocortin drug development broadly, but KPV itself remains. All KPV sold by peptide-studies suppliers is for clinical investigation only. <\/p>\n<h3>Can KPV be taken orally for IBD studies?<\/h3>\n<p>Yes. Unlike most peptides which are degraded by gastric enzymes, KPV retains some anti-inflammatory activity via the oral route in published IBD and colitis studies. This makes it unusually flexible for GI-inflammation studies where oral delivery targets the GI tract directly. Study protocols vary by model \u2014 SC remains the dominant systemic route. <\/p>\n<h3>Como deve ser armazenado o KPV?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138\u00a0\u00b0C na embalagem original, est\u00e1veis at\u00e9 36 meses. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138\u00a0\u00b0C, utilizar no prazo de 30 dias. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda. <\/p>\n<h3>Como devo reconstituir o KPV?<\/h3>\n<p>Siga o gr\u00e1fico de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco, agite suavemente e aguarde 5-10 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> agite. <\/p>\n<h3>Can KPV and BPC-157 be stacked in studies?<\/h3>\n<p>Yes \u2014 this is one of the most common studies combinations for GI and connective-tissue inflammation. KPV provides upstream NFkB-pathway anti-inflammatory signaling; <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> proporciona atividade de repara\u00e7\u00e3o tecidual e de fatores de crescimento atrav\u00e9s da via VEGF. Os mecanismos s\u00e3o complementares em vez de sobrepostos. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>A MedsBase disp\u00f5e de KPV em frascos liofilizados de 5 mg e 10 mg. Cada dosagem est\u00e1 dispon\u00edvel em embalagens de 10, 20 ou 30 frascos. Todos os frascos s\u00e3o fornecidos com pureza superior a 99% por HPLC e um certificado de an\u00e1lise mediante pedido. <\/p>\n<h3>Does KPV cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile. Because KPV has no melanocortin-receptor activity, the pigmentation, arousal, and blood-pressure effects sometimes seen with full MC agonists do not occur with KPV. No significant off-target signals have been identified at typical doses. Long-term human safety data are not available. <\/p>\n<h3>Qual \u00e9 a meia-vida do KPV?<\/h3>\n<p>KPV (Lys-Pro-Val) is a tripeptide with a short plasma half-life consistent with small unmodified peptides \u2014 estimated at under 30 minutes. Its primary application is gastrointestinal, where local delivery studies show effects on gut epithelial cells and immune cell populations that persist beyond plasma detection, attributed to direct receptor interaction at the intestinal mucosa. <\/p>\n<h3>How does KPV reduce inflammation in study models?<\/h3>\n<p>O KPV \u00e9 o tripept\u00eddeo C-terminal da \u03b1-MSH (hormona estimulante de melan\u00f3citos alfa) e ret\u00e9m grande parte da atividade anti-inflamat\u00f3ria do pept\u00eddeo original atrav\u00e9s da ativa\u00e7\u00e3o do MC1R. Em modelos de colite e les\u00e3o intestinal, o KPV reduz a sinaliza\u00e7\u00e3o do NF-\u03baB, diminui a produ\u00e7\u00e3o de citocinas pr\u00f3-inflamat\u00f3rias (IL-1\u03b2, IL-6, TNF-\u03b1) e promove a integridade da barreira epitelial intestinal. O seu pequeno tamanho facilita a absor\u00e7\u00e3o direta pelas c\u00e9lulas epiteliais, independentemente de prote\u00ednas transportadoras. <\/p>\n<h3>Posso encomendar KPV para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia KPV para todo o mundo a partir da nossa rede dedicada de envio de pept\u00eddeos. As encomendas apenas de pept\u00eddeos qualificam-se para o nosso servi\u00e7o de envio aut\u00f3nomo de pept\u00eddeos. As encomendas s\u00e3o enviadas em embalagens com controlo de temperatura e com rastreio completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/pt-pt\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/pt-pt\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpo sem cortisol\/prolactina<\/li>\n<li><a href=\"\/pt-pt\/cjc-1295-with-dac\/\"><strong>CJC-1295 com DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH com meia-vida prolongada<\/li>\n<li><a href=\"\/pt-pt\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leia o nosso guia completo baseado em evid\u00eancias: <a href=\"https:\/\/medsbase.com\/pt-pt\/kpv-peptide-anti-inflammatory-guide\/\"><strong>KPV \u2014 the C-terminal alpha-MSH fragment for anti-inflammatory studies<\/strong><\/a>. Covers NFkB pharmacology, mast-cell stabilization, IBD studies history, oral and SC protocols, and stacking with BPC-157.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Apoia a repara\u00e7\u00e3o tecidular<br \/>\n\u2705 Reduz o stresse oxidativo<br \/>\n\u2705 Modula a resposta imunit\u00e1ria<br \/>\n\u2705 Promove a resili\u00eancia celular<br \/>\n\u2705 Melhora a integridade epitelial<\/p>\n<p><strong>KPV<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70964,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5472,5473],"class_list":["post-69013","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-kpv","product_tag-lysine-proline-valine","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/69013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=69013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70964"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=69013"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=69013"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=69013"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=69013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}